Dr. Nadia Waheed

Nadia is a retinal specialist and the former Chief Medical Officer at Gyroscope Therapeutics which was acquired by Novartis in 2022 for up to $1.5 billion. Prior to her time at Gyroscope, Nadia was Director of the Boston Image Reading Center and Consultant at the New England Eye Center, Tufts University School of Medicine in Boston. She trained in Ophthalmology at the Harvard Medical School/Mass Eye and Ear Infirmary Program in Ophthalmology, which was followed by a fellowship in retina at the Harvard Medical School/Mass Eye and Ear Infirmary in Boston. Nadia received her medical degree from the Aga Khan University Medical School, Pakistan, and a Master in Public Health from the Harvard School of Public Health. Nadia has authored over 100 papers in peer-reviewed publications, has co-authored and edited three books in Ophthalmology and has participated as a principal investigator or co-investigator in multiple clinical trials.